Test

cgadmin's picture

Submitted by cgadmin on Wed, 07/12/2017 - 11:25

THIS IS THE HEADLINE FOR COMMUNICATING DIRECTLY TO YOUR PARTICIPANTS.

It is a long established fact that a reader will be distracted by the readable content of a page when looking at its layout. The point of using Lorem Ipsum is that it has a more-or-less normal distribution of letters, as opposed to using 'Content here, content here', making it look like readable English. Many desktop publishing packages and web page editors now use Lorem Ipsum as their default model text, and a search for 'lorem ipsum' will uncover many web sites still in their infancy.

Head and Neck Cancer Treatment Update: Pembrolizumab, Nivolumab and PD-L1 Markers

dbrock's picture

Submitted by dbrock on Tue, 05/23/2017 - 17:37

Video

Drs. Jared Weiss, Assistant Professor, Clinical Research Hematology/Oncology, University of North Carolina School of Medicine, and Josh Bauml, Assistant Professor of Medicine, Hospital of the University of Pennsylvania, join GRACE to discuss updates relating to pembrolizumab, nivolumab and PD-L1 markers for head and neck cancers.

Judy Hill

Judy Hill, a supporter of the GRACE community as long as we can remember. Judy attended every event and was always a force in the fight against lung cancer. A sweet and caring person, a teacher, an avid reader and sports fan, Judy loved crossword puzzles and walking in her lovely neighborhood. She shared herself with us all. She passed away after 7 years living with cancer, leaving a husband, parents, brother, sister and many friends and admirers. She is greatly missed by everyone who knew and loved her.

How GRACE Helped

dbrock's picture

Submitted by dbrock on Wed, 05/10/2017 - 11:12

Video

Two of GRACE's earliest followers, Laya Dogmetchi and Jim Celebucki, talk about how the Global Resource for Advancing Cancer Education helps cancer patients and their families make informed decisions about their care.

Pages

 
Subscribe to CancerGRACE RSS